secwatch.observer — SEC 8-K summary
======================================

Issuer:     Boundless Bio, Inc. (BOLD)
CIK:        0001782303
Form:       8-K
Filed at:   2026-08-28T21:25:54+00:00
Accession:  0001193125-26-374787
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boundless Bio amends Serapha merger: RSU conversion, pre-funded warrants, vote standard
--------------------------------------------------------------------------------

- Amendment No. 1 (8/28/26) to the June 22, 2026 merger agreement among Boundless Bio, Boulder Merger Sub, and Serapha Bio.
- Serapha RSUs (vested or unvested) convert into Assumed RSUs covering Boundless Bio common stock at the Exchange Ratio.
- Pre-funded warrants with $0.00001 exercise price issued as Merger Consideration for holders exceeding Beneficial Ownership Limits (0–19.99%).
- Vote standard for increasing authorized Boundless Bio shares changed to majority of shares properly cast, not majority outstanding.
- Company Pre-Closing Financing definitions clarified; cash proceeds of at least the minimum amount required by 8/28/26 close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782303/000119312526374787/0001193125-26-374787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782303/000119312526374787/d111273d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-374787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer